Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Hartmut Peter

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Rheumatology (Oxford, England)|August 13, 2009
Disseminated tuberculosis in a patient with idiopathic CD4+ lymphocytopeniaJan Thoden, Nils Venhoff, Michael Daskalakis, et al.
Clinical Immunology (Orlando, Fla.)|August 30, 2011
Analysis of bulk and virus-specific CD8+ T cells reveals advanced differentiation of CD8+ T cells in patients with common variable immunodeficiencyMartin Kuntz, Sigune Goldacker, Hubert E Blum, et al.
Clinical and Experimental Rheumatology|September 1, 2012
Elevated serum osteopontin levels in idiopathic retroperitoneal fibrosisMoritz Binder, Sophie Christoph, Bettina Sehnert, et al.
The Journal of Allergy and Clinical Immunology|September 8, 2020
Targeting FcRn for immunomodulation: Benefits, risks, and practical considerationsHans-Hartmut Peter, Hans D Ochs, Charlotte Cunningham-Rundles, et al.
Arthritis and Rheumatism|February 7, 2003
Transcription factor early growth response 1 activity up-regulates expression of tissue inhibitor of metalloproteinases 1 in human synovial fibroblastsWilhelm K Aicher, Dorothea Alexander, Christian Haas, et al.
Blood|February 28, 2002
Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous diseaseKlaus Warnatz, Axel Denz, Ruth Dräger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 25, 2010
B cell receptor-mediated calcium signaling is impaired in B lymphocytes of type Ia patients with common variable immunodeficiencyChristian Foerster, Nadine Voelxen, Mirzokhid Rakhmanov, et al.
Plos One|May 26, 2012
Impact of rituximab on immunoglobulin concentrations and B cell numbers after cyclophosphamide treatment in patients with ANCA-associated vasculitidesNils Venhoff, Nora M Effelsberg, Ulrich Salzer, et al.
Seminars in Arthritis and Rheumatism|April 14, 2004
Differential efficacy of human recombinant interferon-alpha2a on ocular and extraocular manifestations of Behçet disease: results of an open 4-center trialIna Kötter, Reinhard Vonthein, Manfred Zierhut, et al.
Advances in Experimental Medicine and Biology|August 16, 2003
Human recombinant interferon-alpha2a (rhIFN alpha2a) for the treatment of Behçet's disease with sight-threatening retinal vasculitisIna Kötter, Manfred Zierhut, Anja Eckstein, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Rheumatology (Oxford, England)|August 13, 2009
Disseminated tuberculosis in a patient with idiopathic CD4+ lymphocytopeniaJan Thoden, Nils Venhoff, Michael Daskalakis, et al.
Clinical Immunology (Orlando, Fla.)|August 30, 2011
Analysis of bulk and virus-specific CD8+ T cells reveals advanced differentiation of CD8+ T cells in patients with common variable immunodeficiencyMartin Kuntz, Sigune Goldacker, Hubert E Blum, et al.
Clinical and Experimental Rheumatology|September 1, 2012
Elevated serum osteopontin levels in idiopathic retroperitoneal fibrosisMoritz Binder, Sophie Christoph, Bettina Sehnert, et al.
The Journal of Allergy and Clinical Immunology|September 8, 2020
Targeting FcRn for immunomodulation: Benefits, risks, and practical considerationsHans-Hartmut Peter, Hans D Ochs, Charlotte Cunningham-Rundles, et al.
Arthritis and Rheumatism|February 7, 2003
Transcription factor early growth response 1 activity up-regulates expression of tissue inhibitor of metalloproteinases 1 in human synovial fibroblastsWilhelm K Aicher, Dorothea Alexander, Christian Haas, et al.
Blood|February 28, 2002
Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous diseaseKlaus Warnatz, Axel Denz, Ruth Dräger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 25, 2010
B cell receptor-mediated calcium signaling is impaired in B lymphocytes of type Ia patients with common variable immunodeficiencyChristian Foerster, Nadine Voelxen, Mirzokhid Rakhmanov, et al.
Plos One|May 26, 2012
Impact of rituximab on immunoglobulin concentrations and B cell numbers after cyclophosphamide treatment in patients with ANCA-associated vasculitidesNils Venhoff, Nora M Effelsberg, Ulrich Salzer, et al.
Seminars in Arthritis and Rheumatism|April 14, 2004
Differential efficacy of human recombinant interferon-alpha2a on ocular and extraocular manifestations of Behçet disease: results of an open 4-center trialIna Kötter, Reinhard Vonthein, Manfred Zierhut, et al.
Advances in Experimental Medicine and Biology|August 16, 2003
Human recombinant interferon-alpha2a (rhIFN alpha2a) for the treatment of Behçet's disease with sight-threatening retinal vasculitisIna Kötter, Manfred Zierhut, Anja Eckstein, et al.
Pageof 6